SK3632002A3 - Piperidine quinolyl propyl derivatives, preparation method and compositions containing same - Google Patents

Piperidine quinolyl propyl derivatives, preparation method and compositions containing same Download PDF

Info

Publication number
SK3632002A3
SK3632002A3 SK363-2002A SK3632002A SK3632002A3 SK 3632002 A3 SK3632002 A3 SK 3632002A3 SK 3632002 A SK3632002 A SK 3632002A SK 3632002 A3 SK3632002 A3 SK 3632002A3
Authority
SK
Slovakia
Prior art keywords
propyl
piperidine
methoxyquinolin
acetic acid
group
Prior art date
Application number
SK363-2002A
Other languages
English (en)
Slovak (sk)
Inventor
Jean-Luc Malleron
Michel Tabart
Jean-Christophe Carry
Michel Evers
Ahmad Youssef El
Serge Mignani
Fabrice Viviani
Michel Cheve
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of SK3632002A3 publication Critical patent/SK3632002A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
SK363-2002A 1999-09-17 2000-09-14 Piperidine quinolyl propyl derivatives, preparation method and compositions containing same SK3632002A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9911679A FR2798656B1 (fr) 1999-09-17 1999-09-17 Derives de la quinolyl propyl piperidine, leur preparation et les compositions qui les contiennent
PCT/FR2000/002541 WO2001025227A2 (fr) 1999-09-17 2000-09-14 Derives de la quinolyl propyl piperidine et leur utilisation en tant que antibacteriens

Publications (1)

Publication Number Publication Date
SK3632002A3 true SK3632002A3 (en) 2003-04-01

Family

ID=9549990

Family Applications (1)

Application Number Title Priority Date Filing Date
SK363-2002A SK3632002A3 (en) 1999-09-17 2000-09-14 Piperidine quinolyl propyl derivatives, preparation method and compositions containing same

Country Status (30)

Country Link
EP (2) EP1484328B1 (de)
JP (1) JP2004527448A (de)
KR (1) KR20020038757A (de)
CN (1) CN1374959A (de)
AP (1) AP2002002459A0 (de)
AT (1) ATE284399T1 (de)
AU (1) AU7429500A (de)
BG (1) BG106524A (de)
BR (1) BR0014060A (de)
CA (1) CA2383836A1 (de)
CZ (1) CZ2002940A3 (de)
DE (2) DE60016611T2 (de)
DZ (1) DZ3195A1 (de)
EA (1) EA005183B1 (de)
EE (1) EE200200138A (de)
FR (1) FR2798656B1 (de)
GE (1) GEP20043223B (de)
HR (1) HRP20020214A2 (de)
HU (1) HUP0204283A3 (de)
IL (1) IL148720A0 (de)
MA (1) MA26820A1 (de)
MX (1) MXPA02001979A (de)
NO (1) NO20021253L (de)
OA (1) OA12022A (de)
PL (1) PL354809A1 (de)
SK (1) SK3632002A3 (de)
TN (1) TNSN00184A1 (de)
WO (1) WO2001025227A2 (de)
YU (1) YU19002A (de)
ZA (1) ZA200202073B (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9822440D0 (en) 1998-10-14 1998-12-09 Smithkline Beecham Plc Medicaments
GB9917408D0 (en) 1999-07-23 1999-09-22 Smithkline Beecham Plc Compounds
GB9917406D0 (en) 1999-07-23 1999-09-22 Smithkline Beecham Plc Compounds
PL366335A1 (en) 2000-07-26 2005-01-24 Smithkline Beecham P.L.C. Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
GB0031086D0 (en) * 2000-12-20 2001-01-31 Smithkline Beecham Plc Medicaments
GB0101577D0 (en) 2001-01-22 2001-03-07 Smithkline Beecham Plc Compounds
GB0112836D0 (en) 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
GB0112834D0 (en) 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
JP4508650B2 (ja) 2002-01-29 2010-07-21 グラクソ グループ リミテッド アミノピペリジン化合物、当該化合物の製法および当該化合物を含有する医薬組成物
EP2181996A1 (de) 2002-01-29 2010-05-05 Glaxo Group Limited Aminopiperidinderivate
AR040336A1 (es) 2002-06-26 2005-03-30 Glaxo Group Ltd Compuesto de piperidina, uso del mismo para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para preparar dicho compuesto
TW200406413A (en) 2002-06-26 2004-05-01 Glaxo Group Ltd Compounds
FR2842807A1 (fr) * 2002-07-23 2004-01-30 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, procede et intermediaires de preparation et compositions les renfermant
FR2844270B1 (fr) 2002-09-11 2006-05-19 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leur procede et intermediaires de preparation et les compositions qui les contiennent
FR2844268B1 (fr) * 2002-09-11 2004-10-22 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leurs procedes et intermediaires de preparation et les compositions qui les contiennent
WO2004035569A2 (de) * 2002-10-10 2004-04-29 Morphochem Aktiengesellschaft für kombinatorische Chemie Neue verbindungen mit antibakterieller aktivität
DE60331849D1 (de) 2002-11-05 2010-05-06 Glaxosmithkline Llc Antibakterielle wirkstoffe
EP1560488B1 (de) 2002-11-05 2010-09-01 Glaxo Group Limited Antibakterielle mittel
EP1567520B1 (de) 2002-12-04 2008-10-15 Glaxo Group Limited Chinoline und stickstoffhaltige derivatedavon und deren verwendung als antibakterielle mittel
EP1799674B1 (de) * 2004-10-05 2010-05-05 Actelion Pharmaceuticals Ltd. Neue piperidin-antibiotika
WO2006038172A1 (en) * 2004-10-05 2006-04-13 Actelion Pharmaceuticals Ltd New piperidine antibiotics
JP2008528587A (ja) 2005-01-25 2008-07-31 グラクソ グループ リミテッド 抗菌剤
JP2008528598A (ja) 2005-01-25 2008-07-31 グラクソ グループ リミテッド 抗菌剤
US7592334B2 (en) 2005-01-25 2009-09-22 Glaxo Group Limited Antibacterial agents
WO2006081178A2 (en) 2005-01-25 2006-08-03 Glaxo Group Limited Antibacterial agents
EP1981881B1 (de) 2006-01-26 2011-12-07 Actelion Pharmaceuticals Ltd. Tetrahydropyran-antibiotika
DE602007009205D1 (de) 2006-04-06 2010-10-28 Glaxo Group Ltd Pyrrolochinoxalinonderivate als antibakterielle mittel
GB0613208D0 (en) 2006-07-03 2006-08-09 Glaxo Group Ltd Compounds
EP1992628A1 (de) 2007-05-18 2008-11-19 Glaxo Group Limited Derivate und Analoge von N-Ethylquinolonen und N-Ethylazaquinolonen
MX2009012117A (es) * 2007-05-09 2009-11-23 Pfizer Composiciones y derivados heterociclicos sustituidos y su uso farmaceutico como antibacterianos.
EP2080761A1 (de) 2008-01-18 2009-07-22 Glaxo Group Limited Verbindungen
JP2012505866A (ja) 2008-10-17 2012-03-08 グラクソ グループ リミテッド 抗菌剤として使用される三環式窒素化合物
WO2010081874A1 (en) 2009-01-15 2010-07-22 Glaxo Group Limited Naphthyridin-2 (1 h)-one compounds useful as antibacterials
KR102365952B1 (ko) * 2013-10-14 2022-02-22 에자이 알앤드디 매니지먼트 가부시키가이샤 선택적으로 치환된 퀴놀린 화합물
BR112017003705B1 (pt) 2014-08-22 2022-07-12 Glaxosmithkline Intellectual Property Development Limited Compostos contendo nitrogênio tricíclicos para o tratamento de infecção por neisseria gonorrhoea
TW201722965A (zh) 2015-08-16 2017-07-01 葛蘭素史密斯克藍智慧財產發展有限公司 用於抗菌應用之化合物
SI3889145T1 (sl) 2015-12-17 2024-05-31 Merck Patent Gmbh 8-ciano-5-piperidino-kinolini kot antagonisti tlr7/8 in njihove uporabe za zdravljenje imunskih motenj
DK3497094T3 (da) 2016-08-08 2023-05-15 Merck Patent Gmbh Tlr7/8-antagonister og anvendelser deraf

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1051413B1 (de) * 1998-01-26 2003-06-04 SmithKline Beecham plc Chinolinderivate als antibakterielles arzneimittel
WO2000043383A1 (en) * 1999-01-20 2000-07-27 Smithkline Beecham P.L.C. Piperidinylquinolines as protein tyrosine kinase inhibitors

Also Published As

Publication number Publication date
KR20020038757A (ko) 2002-05-23
HRP20020214A2 (en) 2005-04-30
EP1218370A2 (de) 2002-07-03
MXPA02001979A (es) 2002-08-20
YU19002A (sh) 2005-06-10
EP1484328A1 (de) 2004-12-08
WO2001025227A2 (fr) 2001-04-12
DE60034713D1 (de) 2007-06-14
CZ2002940A3 (cs) 2002-07-17
IL148720A0 (en) 2002-09-12
FR2798656A1 (fr) 2001-03-23
HUP0204283A3 (en) 2004-07-28
EP1218370B1 (de) 2004-12-08
EA200200374A1 (ru) 2002-10-31
WO2001025227A3 (fr) 2001-11-22
TNSN00184A1 (fr) 2005-11-10
CA2383836A1 (fr) 2001-04-12
DE60034713T2 (de) 2008-01-17
EP1484328B1 (de) 2007-05-02
GEP20043223B (en) 2004-04-26
BR0014060A (pt) 2002-05-21
MA26820A1 (fr) 2004-12-20
EE200200138A (et) 2003-06-16
DZ3195A1 (fr) 2001-04-12
BG106524A (en) 2003-01-31
JP2004527448A (ja) 2004-09-09
AU7429500A (en) 2001-05-10
DE60016611T2 (de) 2005-12-22
NO20021253L (no) 2002-04-24
HUP0204283A2 (hu) 2003-04-28
ZA200202073B (en) 2003-08-27
AP2002002459A0 (en) 2002-06-30
CN1374959A (zh) 2002-10-16
FR2798656B1 (fr) 2004-12-17
DE60016611D1 (de) 2005-01-13
ATE284399T1 (de) 2004-12-15
PL354809A1 (en) 2004-02-23
EA005183B1 (ru) 2004-12-30
NO20021253D0 (no) 2002-03-13
OA12022A (fr) 2006-04-19

Similar Documents

Publication Publication Date Title
SK3632002A3 (en) Piperidine quinolyl propyl derivatives, preparation method and compositions containing same
US6403610B1 (en) Quinolylpropylpiperidine derivatives, their preparation and the compositions which comprise them
AU2018267569B2 (en) Bicyclic heterocyclyl derivatives as IRAK4 inhibitors
US6602884B2 (en) Quinolylpropylpiperidine derivatives, their preparation, and compositions containing them
AU2016224974B2 (en) Substituted pyrazole compounds as serine protease inhibitors
US7622471B2 (en) Pyrazole derivatives having a pyridazine and pyridine functionality
AU2002253219B8 (en) Quinolyl propyl piperidine derivatives, the preparation thereof and compositions containing same
SK5822003A3 (en) Heterocylcylalkyl piperidine derivatives and their use as antimicrobial agents
WO2006126676A1 (ja) 置換アルキル基を有する環状アミン誘導体
WO2005051913A1 (ja) ヘテロアリール環を有する環状アミン誘導体
AU2003278297A1 (en) Quinolylpropylpiperidine derivatives and use thereof as antimicrobial agents
JP2008540575A (ja) 多環系化合物とその使用の方法
JP2002521382A (ja) ロータマーゼ酵素の阻害薬としてのヘテロ環式化合物
EP0307141B1 (de) Oxazole und Thiazole zur Behandlung seniler Demenz
HU198036B (en) Process for production of derivatives of 3-piperidil-/1h/-indasole and medical preparatives containing them
EP1831194A1 (de) Heterocyclische mchr1-antagonisten und deren verwendung in der therapie
WO2009060030A1 (en) Heteroaryl-substituted 2-pyridinylmethylamine derivatives
TW202241858A (zh) 適用於治療血脂異常之新穎化合物
TWI475021B (zh) 新穎（雜環－四氫吡啶）（哌基）－１－烷酮及（雜環－二氫吡咯啶）（哌基）－１－烷酮衍生物及其作為ｐ７５抑制劑之用途
US20230365551A1 (en) Inhibitors of human respiratory syncytial virus and metapneumovirus
KR20220152159A (ko) 신규한 헤테로사이클 화합물 및 이의 용도